EU: Provitamins And Vitamins - Market Report. Analysis And Forecast To 2025
This report focuses on the EU vitamin market, providing a comprehensive analysis and the most recent data on its market size and volume, EU trade, price dynamics, domestic production, and turnover in the industry. The market trends section reveals the main issues and uncertainties concerning the industry, while the medium-term outlook uncovers market prospects. The attractivity index (IB Index) summarizes the source of existing opportunities as they appear in this market, as well as an interpretation of the trade figures.
EU(28) - Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Croatia, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, the United Kingdom.
Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent. These products should be understood as organic compounds (they belong to HS chapter 29), not as ready to be used as pharmaceutical products/medicaments. In this sense, the products making up the code 35250-1 are distinct from the medicaments containing them.
Vitamin market size and value;
EU production, split by EU Member States;
Vitamin production by type;
Profiles of the leading companies;
EU trade (intra and extra);
Prices for vitamin (producer, import and export);
Trade structure and market channels;
Vitamin market outlook to 2025;
Per Capita Consumption.
Why buy this report:
This report will provide you with deeper insights into current market developments with the latest data and underlying market affecting themes, allowing you to rewire your business around them.Please note: The report will be provided within 3 working days after ordering.